Live Analyst Rating Changes 28472 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Allison Bratzel
PIPR

Allison Bratzel

Piper Sandler
Wall Street Analyst
★★★★☆
#795
on 13Foresight · ranked by our own returns
61%
Success Rate
+6.5%
Average Return
33 of 54 calls profitable · +2.6% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 61% of Allison Bratzel's ratings turned a profit when each position was held for 1 year — averaging +6.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

90 Buy 15 Hold 0 Sell
Allison's Stock Coverage 25 ratings · 2026-08-29
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
BMRN
BioMarin Pharmaceutical
 Aug 26, 2026 BUY Strong Buy
+47.4% avg upside
52 analysts
$88.00
36.92% Upside
 -0.5% ·
RIGL
Rigel
 Aug 17, 2026 HOLD Strong Buy
-41.7% avg upside
17 analysts
$49.00
6.61% Upside
 +6.3% ·
AKBA
Akebia Therapeutics
 Aug 17, 2026 BUY Strong Buy
+960.1% avg upside
16 analysts
$4.00
346.10% Upside
 +11.4% ·
ARDX
Ardelyx
 Aug 17, 2026 BUY Strong Buy
+241.9% avg upside
21 analysts
$15.00
297.86% Upside
 -4.2% ·
ARGX
Argenx Se
 Aug 17, 2026 BUY Strong Buy
-20.2% avg upside
47 analysts
$1215.00
17.17% Upside
 +7.2% ·
COGT
Cogent Biosciences
 Aug 17, 2026 BUY Strong Buy
+5.2% avg upside
26 analysts
$55.00
54.49% Upside
 -3.0% ·
MGTX
Meiragtx Holdings
 Aug 17, 2026 BUY Strong Buy
+88.1% avg upside
13 analysts
$30.00
116.30% Upside
 +7.7% ·
ALXO
ALX Oncology Holdings
 Aug 17, 2026 BUY Strong Buy
+796.0% avg upside
11 analysts
$4.00
98.95% Upside
 +0.5% ·
HUMA
Humacyte
 Aug 17, 2026 HOLD Strong Buy
+903.3% avg upside
11 analysts
$1.00
50.34% Upside
 +23.5% ·
IMRX
Immuneering
 Aug 17, 2026 BUY Strong Buy
+257.4% avg upside
12 analysts
$12.00
136.22% Upside
 +1.5% ·
BHVN
Biohaven Ltd.
 Aug 17, 2026 BUY Buy
+50.2% avg upside
25 analysts
$30.00
89.14% Upside
 -5.4% ·
CDXS
Codexis
 Aug 17, 2026 BUY Strong Buy
+516.6% avg upside
13 analysts
$8.00
387.79% Upside
 +0.0% ·
INCY
Incyte
 Aug 17, 2026 BUY Buy
-13.0% avg upside
48 analysts
$130.00
3.44% Upside
 +0.7% ·
IONS
Ionis Pharmaceuticals
 Aug 17, 2026 BUY Strong Buy
+28.5% avg upside
43 analysts
$94.00
54.22% Upside
 +6.5% ·
TVTX
Travere Therapeutics
 Aug 17, 2026 BUY Strong Buy
-13.0% avg upside
22 analysts
$68.00
2.41% Upside
 +5.5% ·
RARE
Ultragenyx Pharmaceutical
 Aug 17, 2026 BUY Strong Buy
+160.5% avg upside
36 analysts
$68.00
160.29% Upside
 -1.6% ·
ABCL
AbCellera Biologics
 Aug 07, 2026 BUY Strong Buy
+38.8% avg upside
15 analysts
$12.00
2.85% Upside
 +73.4% ·
REPL
Replimune Group
 Aug 07, 2026 BUY Strong Buy
+48.1% avg upside
14 analysts
$14.00
11.14% Downside
 +28.5% ·
ABVX
Abivax SA Sponsored ADR
 Jul 09, 2026 BUY Strong Buy
+18.4% avg upside
15 analysts
$175.00
54.86% Upside
 -18.8% ·
ENGN
enGene Holdings
 May 08, 2026 HOLD Buy
+445.6% avg upside
13 analysts
$4.00
116.81% Upside
 +20.7% ·
TYRA
Tyra Bioscience
 Mar 20, 2026 BUY Strong Buy
+76.0% avg upside
17 analysts
$56.00
118.70% Upside
 -32.9% ·
SRRK
Scholar Rock Holding
 Mar 04, 2026 BUY Strong Buy
+1.0% avg upside
23 analysts
$58.00
1.20% Downside
 +24.9% ·
IOBTQ
IO Biotech
 Jan 23, 2026 HOLD Hold
+4714900.0% avg upside
6 analysts
$0.50
499899.97% Upside
 · ·
ROIV
Roivant Sciences
 Jul 18, 2024 BUY Strong Buy
-1.9% avg upside
17 analysts
$22.00
38.08% Downside
 +3.0% ·
SLDB
Solid Biosciences
 Mar 14, 2024 BUY Strong Buy
+67.2% avg upside
24 analysts
$20.00
101.65% Upside
 -58.6% ·
🔒 20 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Allison Bratzel — Frequently Asked Questions
How accurate are Allison Bratzel's stock ratings?
Based on the calls 13Foresight could measure, about 61% of Allison's ratings were profitable over a one-year hold, with an average return of +6.4% per rating, or +2.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Allison ranked on 13Foresight?
Allison Bratzel is currently ranked #795 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Allison cover?
Allison most recently has ratings on BMRN, RIGL, AKBA, ARDX, ARGX, COGT, MGTX, ALXO, HUMA, IMRX, BHVN, CDXS and 13 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.